GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$28.52
Tradestie Score
63
Market Cap
$19.56B
P/E Ratio
20.9
Revenue Growth
0.3%
Analyst Upside
+29.1%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$116.86
|
$16.93B | 16.1 | 61 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.77
|
$15.70B | 29.4 | 63 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.42
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$274.50
|
$12.36B | 31.3 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$55.85
|
$11.09B | 17.9 | 63 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.13
|
$10.76B | - | 59 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$79.76
|
$10.74B | - | 58 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.99
|
$10.53B | 41.6 | 63 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$81.80
|
$10.49B | - | 64 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$77.19
|
$10.22B | - | 62 | Compare |
More GMAB Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry